Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)
AI disclosure
Summary
**media[1079221]**Lilly licenses Hanmi's sonefpeglutide (LAPSGLP-2 analog) for multiple indications